| # | Drug | Count |
|---|---|---|
| 0 | PREGABALIN | 14 |
| 1 | BUPROPION | 10 |
| 2 | LORAZEPAM | 10 |
| 3 | BISOPROLOL FUMARATE | 9 |
| 4 | CISPLATIN | 9 |
| 5 | DOCETAXEL | 9 |
| 6 | DOCETAXEL ANHYDROUS | 9 |
| 7 | PACLITAXEL | 9 |
| 8 | DULOXETINE | 6 |
| 9 | DULOXETINE HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROPERIDOL | 1 | 0.0006 |
| 1 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 2 | NITROUS OXIDE | 1 | 0.0005 |
| 3 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 4 | DIMENHYDRINATE | 3 | 0.0003 |
| 5 | CENOBAMATE | 2 | 0.0002 |
| 6 | NORGESTIMATE AND ETHINYL ESTRADIOL | 1 | 0.0002 |
| 7 | HALOPERIDOL LACTATE | 5 | 0.0002 |
| 8 | SIPULEUCEL-T | 1 | 0.0002 |
| 9 | ICATIBANT ACETATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Typical Antipsychotic [EPC] | 5 | 0.0002 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Cannabinoid [EPC] | 1 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |